> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# 54 ANDAs Withdrawn by Watson and Barr Labs
- URL: https://www.fdaweb.com/54-andas-withdrawn-by-watson-and-barr-labs/
- Published: 2017-10-24T12:00:00.000Z
- Updated: 2026-09-14T22:57:50.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5139950

*Federal Register* notice: FDA has withdrawn the marketing approval of 54 ANDAs requested by Watson Laboratories and Barr Laboratories. The companies notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn. To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2017-10-24/pdf/2017-23046.pdf?ref=fdaweb.com).